Tech Company Financing Transactions
Parabon NanoLabs Funding Round
CIT GAP Fund participated in a $50 thousand funding round for Parabon NanoLabs. The round was announced on 6/30/2012.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$50,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Nanotechnology
Mailing Address
11260 Roger Bacon Dr. 406
Reston, VA 20190
USA
Reston, VA 20190
USA
Phone
Website
Email Address
Overview
Parabon NanoLabs, Inc. (PNL) is a nano-pharmaceutical company that develops novel therapeutics using its proprietary Essemblix or Drug Design Platform -- a powerful combination of computer-aided design (CAD) software for designing macromolecules and nanoscale fabrication technology for their production.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Michael Norton
President
Steven Armentrout
Vice President
David Danley
Browse more venture capital transactions:
Prev: 6/30/2012: Ceregene venture capital transaction
Next: 6/30/2012: Rhythm New Media venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs